Explore more publications!
The Boston Examiner
Got News to Share?

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 9, 2026

How to Collect Classic Cars: A Comprehensive Guide for New and Experienced Enthusiasts
January 9, 2026

How to Collect Classic Cars: A Comprehensive Guide for New and Experienced Enthusiasts

Indeterminate EIN Presswire
Vertex Flooring Unveils Distinct Marquetry Flooring Solutions with Expert Craftsmanship and Designs
January 9, 2026

Vertex Flooring Unveils Distinct Marquetry Flooring Solutions with Expert Craftsmanship and Designs

Indeterminate EIN Presswire
R2 Recycling – Worcester Reaffirms Commitment to Secure, Compliant Electronics Recycling for Local Businesses
January 9, 2026

R2 Recycling – Worcester Reaffirms Commitment to Secure, Compliant Electronics Recycling for Local Businesses

Indeterminate EIN Presswire
Access Fixtures Announces The BABA Qualified Light Fixtures for 2026
January 9, 2026

Access Fixtures Announces The BABA Qualified Light Fixtures for 2026

Indeterminate EIN Presswire
BREAKING: Aquestive Therapeutics Investigated for Securities Fraud After FDA Identifies Deficiencies; Investors Should Contact Block & Leviton To Potentially Recover Losses
January 9, 2026

BREAKING: Aquestive Therapeutics Investigated for Securities Fraud After FDA Identifies Deficiencies; Investors Should Contact Block & Leviton To Potentially Recover Losses

Indeterminate GlobeNewswire
Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results
January 9, 2026

Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results

Indeterminate GlobeNewswire
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026
January 9, 2026

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

Indeterminate GlobeNewswire
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
January 9, 2026

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones
January 9, 2026

Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones

Indeterminate GlobeNewswire
Global MedTech and Healthcare IT Industry: Accelerating Digital Transformation in Patient Care
January 9, 2026

Global MedTech and Healthcare IT Industry: Accelerating Digital Transformation in Patient Care

Indeterminate GlobeNewswire
uniQure Announces Type A Meeting Scheduled with FDA
January 9, 2026

uniQure Announces Type A Meeting Scheduled with FDA

Indeterminate GlobeNewswire
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
January 9, 2026

Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering

Indeterminate GlobeNewswire
Aktis Oncology Announces Pricing of its Upsized Initial Public Offering
January 9, 2026

Aktis Oncology Announces Pricing of its Upsized Initial Public Offering

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions